基线免疫状态和T细胞克隆动力学与大B细胞淋巴瘤中对CAR-T治疗的持久反应有关
Katie Maurer1,2,3, Isabella N Grabski4, Roch Houot1,5
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood
|September 6, 2024
概括
现在可以预测针对大B细胞淋巴瘤 (LBCL) 的奇默抗原受体T细胞 (CAR-T) 治疗的反应. 基线B细胞水平和淋巴细胞与单细胞的比率可以确定可能受益于CAR-T治疗的患者.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法 细胞疗法
背景情况:
- 使用针对CD19的仿真抗原受体T细胞 (CAR-Ts) 进行的工程细胞疗法改变了复发性/耐药性大B细胞淋巴瘤 (LBCL) 的结果.
- 然而,与成功的CAR-T治疗反应相关的特定细胞和分子特征仍然不完全理解.
研究的目的:
- 在LBCL中确定预治疗患者的免疫特征,这些特征可以预测LBCL中Axicabtagene ciloleucel CAR-T疗法的反应.
- 与治疗反应相关的CAR-T输液产品的细胞组成的特征.
主要方法:
- 单细胞RNA和T细胞受体测序的综合分析,流细胞测量和50名LBCL患者的连续外周血液样本的质量细胞测量.
- 在ZUMA-1试验中99名患者的独立队列中验证预测特征.
主要成果:
- 治疗前的B细胞存在和更高的绝对淋巴细胞数与绝对单细胞数比率 (ALC/AMC) 与更好的CAR-T反应有关.
- 来自应答者的CAR-T产品显示了克隆扩展,激活的CD8+T细胞的丰富.
- 结合B细胞比例 (≥0.5%) 和ALC/AMC (≥1.2) 的预测模型,在符合标准的患者中,改善了1年无进展生存率 (65%vs. 31%).
结论:
- 患者的基线免疫状态显著影响LBCL的CAR-T治疗结果.
- 预测性免疫标志物在治疗前易于评估,可以指导患者的选择,并为治疗策略提供信息.
- 这些发现突出了个性化免疫疗法在LBCL治疗方法的潜力.
相关概念视频
T Cell Activation and Clonal Selection
691
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
691
B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cells of the Adaptive Immune Response
972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

